Welcome to Axis Pro Radha, a podcast that takes just 10 minutes to get you smarter on the collision of tech, business, and politics.

I'm Dan Premack. On today's show, the trade wars with China intensify, and we now know who Elon Musk plans to send around the moon.

But first, marijuana, Maybe around five years ago, I attended

a cannabis industry conference, which yeah, that's a thing. And it was in a pretty nondescript

hotel, maybe 30 miles north of Boston. But clearly the folks milling around in that pretty

dimly lit ballroom realized they were on the verge of

something pretty unusual. The birth of a massive new industry that would probably need to build

its entire logistical supply chain from scratch and quickly. So here's what I mean. Most banks

wouldn't give loans to cannabis companies. Most shipping companies wouldn't ship it, either to

businesses or to consumers. Big agriculture,

big pharma, they didn't want to touch it. And of course, it was illegal, according to the U.S.

federal government. So some of that remains the case today, but the dollars are rising and the

stigma is falling. In fact, we're seeing some brand name companies begin to enter. Just yesterday,

Coca-Cola, yeah, the maker of Coke, said that it's closely

watching an ingredient in cannabis. It might want to infuse into a new category of beverages that it

calls wellness drinks. And Constellation Brands, which makes Corona Beer and Robert Mondavi wines,

it just invested $4 billion into a Canadian cannabis company. And then there's Tillray, which signed a

distribution deal with a Canadian liquor retailer to distribute its products. And also today

said it's gotten approval from the U.S. Food and Drug Administration and DEA. Yeah,

Trump's DEA to export a medical marijuana product to the U.S. for clinical testing related

to a neurological condition known as essential tumor.S. for clinical testing related to a neurological

condition known as essential tumor. TIL-Ray shares, not surprisingly, are soaring on that news,

...